The angiotensin-converting enzyme gene insertion/deletion polymorphism and effects of quinapril and atorvastatin on haemostatic parameters in patients with coronary artery disease [2]

Thrombosis and Haemostasis

Volumn 94, Issue 1, 2005, Pages 224-225

  Potaczek, Daniel P ^a   Undas, Anetta ^a   Iwaniec, Teresa ^a   Szczeklik, Andrew ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; D DIMER; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; QUINAPRIL; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR CELL ADHESION MOLECULE 1;

ALLELE; BLOOD CLOTTING PARAMETERS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HEMOSTASIS; HUMAN; LETTER; PHARMACOGENETICS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 22144482054     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614312     Document Type: Letter

References (12)

1. Cambien F, Poitier O, Lecerf L et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
2. Samani NJ, Thompson JR, O'Toole L et al. A metaanalysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996; 94: 708-12.
3. Wells PS, Rodger MA, Forgie MA et al. The ACE D/D genotype is protective against the development of idiopathic deep wein thrombosis and pulmonaty embolism. Thromb, Haemost 2003; 90: 829-34.
4. Fatini C, Gensini F, Sticchi E et al. ACE DD genotype: an independent predisposition factor to venous thromboembolism. Eur J Clin Invest 2003; 33: 642-7.
5. Jacoby DS, Rader DJ. Renin-angiotensin system and atherothrombotic disease. Arch Intern Med 2003; 163: 1155-64.
6. Undas A, Celinska-Löwenhoff M, Kaczor M et al. New nonlipid effects of statins and their clinical relevance in cardiovascular disease. Thromb Haemost 2004; 91: 1065-77.
7. Basso F, Lowe GDO, McMahon AD et al. Interleukin-6 - 174G>C polymorphism and risk of coronary heart disease in West of Scotland Coronary Prevention Study (WOSCOPS). Atherioscler Thromb Vase Biol 2002; 22: 599-604.
8. Marian AJ, Safavi F, Ferlic L et al. Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin. J Am Coll Cardiol 2000; 35: 89-95.
9. Rigat B, Hubert C, Corvol P et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP-1) (dipeptydyl carboxipeptidase 1). Nucl Acids Res 1992; 20: 1433.
10. Makris TK, Stavroulakis GA, Dafni UG et al. ACE/DD genotype is associated with hemostasis balance disturbances reflecting hypercoagulability and endothelial dysfunction in patients with untreated hypertension. Am Heart J 2000; 140: 760-5.
11. Folsom AR. Haemostatic risk factors for atherothrombotic disease: an epidemiologic view. Thromb Haemost 2001; 86: 366-73.
12. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002; 252: 283-94.